Cabaletta Bio, Inc. (CABA) — Financial statements
Income statement, balance sheet, and cash flow for Cabaletta Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 2↓65.8% | 5↑237.5% | 1↓61.3% | 4↑402.6% | 0.73 | |
| Gross Profit | -2↑65.8% | -5↓237.5% | -1↑61.3% | -4↓402.6% | -0.73 | |
| Operating Expenses | ||||||
| R&D Expenses | 143↑46.8% | 97↑75.4% | 55↑41.0% | 39↑20.9% | 32 | |
| General & Administrative Expenses | 30 | 0.00↓100.0% | 19 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 30↑27.9% | 23↑20.2% | 19↑72.4% | 11↓14.8% | 13 | |
| Other Expenses | -2 | 0.00↑100.0% | -1 | 0.00 | 0.00 | |
| Operating Expenses | 171↑41.8% | 120↑64.3% | 73↑45.1% | 50↑10.7% | 46 | |
| Total Costs & Expenses | 172↑37.6% | 125↑67.6% | 75↑37.9% | 54↑16.9% | 46 | |
| Operating Results | ||||||
| Operating Income | -172↓37.6% | -125↓67.6% | -75↓37.9% | -54↓16.9% | -46 | |
| Depreciation & Amortization | 2↓65.8% | 5↑237.5% | 1↓61.3% | 4↑402.6% | 0.73 | |
| EBITDA | -171↓54.7% | -110↓66.5% | -66↓34.4% | -49↓8.2% | -46 | |
| EBIT | -172↓49.6% | -115↓70.1% | -68↓27.7% | -53↓14.4% | -46 | |
| Interest & Other Income | ||||||
| Net Interest Income | 4↓56.6% | 9↑32.8% | 7↑500.1% | 1↑4750.0% | 0.02 | |
| Interest Income | 6↓39.8% | 10↑43.5% | 7↑500.1% | 1↑4750.0% | 0.02 | |
| Interest Expense | 2↑167.9% | 0.75 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -10↓43.5% | -7↓500.1% | -1↓4750.0% | -0.02 | |
| Other Income / Expenses | 4↓52.7% | 9↑32.8% | 7↑500.1% | 1↑4750.0% | 0.02 | |
| Income Before Tax | -168↓44.9% | -116↓71.2% | -68↓27.7% | -53↓14.4% | -46 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -168↓44.9% | -116↓71.2% | -68↓27.7% | -53↓14.4% | -46 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -168↓44.9% | -116↓71.2% | -68↓27.7% | -53↓14.4% | -46 | |
| Bottom-Line Net Income | -168↓43.5% | -117↓72.9% | -68↓27.7% | -53↓14.4% | -46 | |
| EPS (Basic) | -1.64↑29.9% | -2.34↓41.8% | -1.65↑8.8% | -1.81↓0.6% | -1.80 | |
| EPS (Diluted) | -1.64↑29.9% | -2.34↓41.8% | -1.65↑8.8% | -1.81↓0.6% | -1.80 | |
| Weighted Average Shares | 102↑106.5% | 50↑20.9% | 41↑39.5% | 29↑14.0% | 26 | |
| Weighted Average Diluted Shares | 102↑106.7% | 49↑20.8% | 41↑39.5% | 29↑14.0% | 26 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.